Malignant Pleural Mesothelioma: Timeline and Analysis of 70 Cases

Malignant Pleural Mesothelioma: Timeline and Analysis of 70 Cases

ByHolly Zink

Malignant pleural mesothelioma is a severe cancer linked to asbestos exposure. It often appears decades after exposure. The disease’s early symptoms are unclear, making it hard to diagnose early. Despite being rare, this cancer is a major health concern. It has a poor prognosis and few treatment options. A new article details the study of 70 cases at Getafe University Hospital from 2008 to 2021. Study Overview The study aimed to detail key aspects of malignant pleural mesothelioma. It covered clinical, histological, radiological, and treatment features. The hospital’s Ethics and Research Committee approved it. The sample involved 70 patients, mainly elderly males with an average age of 71. Asbestos exposure was found in 61% of cases. Common symptoms were shortness…

Navigating Treatment Options for Mesothelioma Patients: Immediate vs. Deferred Therapy
|

Navigating Treatment Options for Mesothelioma Patients: Immediate vs. Deferred Therapy

ByHolly Zink

Mesothelioma, a rare cancer linked to asbestos, poses treatment challenges. A new study asks if immediate total therapy is always best for these patients. The study was published in Clinical Lung Cancer. It looks at patients with inoperable pleural mesothelioma. It focuses on those who received immediate treatment or chose to wait before starting therapy. Immediate vs. Deferred Treatment: Understanding the Choices Traditionally, platinum-based chemotherapy has been the standard first-line treatment for inoperable mesothelioma. However, emerging therapies, such as immunotherapy combinations, are changing the treatment landscape. These advancements happened alongside the 2018 American Society of Clinical Oncology (ASCO) guideline. It proposed caution for asymptomatic patients with low disease burden. It suggested they consider a trial of expectant observation before starting…